Table 3 Lipid profile status of the respondents by sex
Male | Female | Total | ||
|---|---|---|---|---|
Variables | N(%) | N(%) | N(%) | p valuea |
Total cholesterol (mg/dl) | ||||
Desirable (< 200) | 20(80.0) | 34(65.4) | 54(70.1) | |
Borderline high (200–239) | 5(20.0) | 13(25.0) | 18(23.4) | |
High (≥ 240) | 0(0.0) | 5(9.6) | 5(6.5) | 0.212 |
Total | 25(100.0) | 52(100.0) | 77(100.0) | |
HDL-c (mg/dl) | ||||
Low (< 40) | 0(0.0) | 0(0.0) | 0(0.0) | |
Borderline (40–59) | 0(0.0) | 1(1.9) | 1(1.3) | |
Desirable (≥ 60) | 25(100.0) | 51(98.1) | 76(98.7) | |
Total | 25(100.0) | 52(100.0) | 77(100.0) | 1.000 |
LDL-c (mg/dl) | ||||
Optimal (< 100) | 10(40.0) | 24(46.2) | 34(44.2) | |
Above optimal (100–129) | 12(48.0) | 19(36.5) | 31(40.3) | |
Borderline high (130–159) | 2(8.0) | 9(17.3) | 11(14.3) | |
High (160–189) | 1(4.0) | 0(0.0) | 1(1.3) | 0.284 |
Total | 25(100.0) | 52(100.0) | 77(100.0) | |
Triglyceride (mg/dl) | ||||
Normal (< 150) | 18(72.0) | 47(90.4) | 65(84.4) | |
Borderline high (150–199) | 5(20.0) | 4(7.7) | 9(11.7) | |
High (200–499) | 2(8.0) | 1(1.9) | 3(3.9) | 0.302 |
Total | 25(100.0) | 52(100.0) | 77(100.0) | |
Atherogenic index of plasma | ||||
Low cardiovascular risk (< 0.11) | 21 (84.0) | 40 (76.9) | 61 (79.2) | |
Intermediate cardiovascular risk (0.11–0.21) | 4 (16.0) | 12(23.1) | 16 (20.8) | |
High cardiovascular risk (> 0.21) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.485 |
Total | 25 (100.0) | 52(100.0) | 77(100.0) | |
Fasting blood glucose (FBG) | ||||
Normal (65-<110 mg/dl) | 24(96.0) | 51(98.1) | 75(97.4) | |
Impaired FBG (110-125 mg/dl) | 1(4.0) | 1(1.9) | 2(2.6) | |
Diabetes mellitus (≥ 126 mg/dl) | 0(0.0) | 0(0.0) | 0(0.0) | 0.547 |
Total | 25(100.0) | 52(100.0) | 77(100.0) | |